Icodextrin is associated with a lower risk of atrial fibrillation in peritoneal dialysis patients.

Aim: Dialysis patients with atrial fibrillation (AF) are at 1.72-fold increased mortality risk. This study investigated whether peritoneal dialysis (PD) patients using icodextrin were at a reduced risk of AF.